Skip to main content
. 2016 May 31;6:26892. doi: 10.1038/srep26892

Table 1. Individual effects of CMV and gender on the absolute numbers of different leukocyte subsets.

  CMV− CMV+ Male Female
Demographic factors
No. (%) 127 (50.8) 123 (49.2) 140 (54.9) 115 (45.1)
Mean age in years (range) 57.6 (50–65) 57.8 (50–65) 57.8 (50–65) 57.5 (50–65)
Mean BMI (range) 25.7 (19–39) 26.0 (18–36) 25.8 (19–35) 25.9 (18–39)
Leukocyte subsets (cells/μl blood)
Granulocytes 2275 [2075–2495] 2198 [2018–2394] 2249 [2060–2457] 2240 [2041–2459]
Monocytes 198.5 [182.6–215.8] 182.5 [168.8–197.3] 192.8 [178.0–208.8] 188.5 [173.0–205.5]
NK cells 143.5 [126.0–163.3] 118.2 [103.0–135.6]* 131.6 [115.7–149.8] 131.3 [114.3–150.9]
Lymphocytes 2179 [2039–2329] 2174 [2030–2328] 1937 [1799–2087] 2367 [2204–2541]****
T cells 1548 [1428–1678] 1428 [1293–1577] 1317 [1201–1445] 1732 [1599–1875]****
 γδ T cells 18.7 [16.01–21.85] 17.4 [14.95–20.17] 16.2 [14.0–18.8] 20.6 [17.6–24.1]*
 CD4/CD8 ratio 3.3 [3.0–3.6] 2.5 [2.3–2.7]**** 2.7 [2.5–2.9] 3.1 [2.8–3.3]
 CD8 T cells 331.7 [299.2–367.8] 368.0 [328.4–412.3]* 317.8 [285.0–354.3] 393.8 [354.9–437.0]*
  CD8 naive 74.0 [63.3–86.4] 64.7 [53.4–78.4] 51.3 [43.2–61.0] 100.9 [87.2–116.8]****
  CD8 CM 13.8 [11.7–16.2] 10.0 [8.5–11.7]* 11.1 [9.3–13.1] 13.0 [11.2–15.1]
  CD8 TemRO 142.4 [126.8–160.0] 151.3 [134.7–169.9] 144.6 [128.7–162.5] 151.9 [135.5–170.2]
  CD8 TemRA 63.2 [54.9–72.9] 102.3 [87.8–119.2]**** 72.3 [62.5–83.7] 88.9 [75.9–104.0]
 CD4 T cells 1084 [994.5–1181] 911.3 [817.0–1016] 852.0 [769.4–943.3] 1205 [1109–1309]****
  CD4 naive 414.0 [363.6–471.4] 310.3 [265.5–362.7]* 290.6 [251.1–336.3] 460.2 [405.3–522.5]****
  CD4 CM 262.1 [234.8–292.6] 206.7 [182.9–233.5]* 213.8 [188.4–242.7] 260.5 [235.3–288.4]*
  CD4 TemRO 202.2 [184.0–222.2] 206.3 [182.7–232.8] 181.2 [162.9–201.5] 239.5 [216.4–265.1]***
  CD4 TemRA 38.1 [32.8–44.3] 44.5 [37.8–52.3] 32.2 [28.0–37.0] 53.9 [45.9–63.3]****
  TFH cells 214.3 [189.4–242.5] 205.3 [178.9–235.6] 186.4 [162.7–213.5] 241.7 [215.9–270.6]*
  Treg cells 107.3 [97.5–118.1] 90.7 [80.4–102.4] 89.0 [79.7–99.4] 113.6 [102.4–126.0]***
   naive Treg 12.6 [10.7–14.7] 11.08 [9.5–13.0] 9.9 [8.4–11.5] 14.7 [12.7–17.0]***
   memory Treg 4.7 [4.0–5.6] 3.2 [2.7–3.8]** 3.9 [3.2–4.7] 4.0 [3.4–4.7]
   CD4+CD45RA+CD25dim 27.0 [23.1–31.5] 21.7 [18.3–25.6] 20.3 [17.3–23.9] 29.7 [25.5–34.4]***
B cells 286.7 [257.8–318.9] 265.8 [241.0–293.0] 259.2 [234.4–286.5] 301.8 [271.8–335.0]*
 transitional 9.5 [8.1–11.2] 7.7 [6.5–9.1] 7.9 [6.8–9.1] 9.7 [8.1–11.5]
 naive mature 175.3 [154.2–199.2] 162.2 [142.1–185.1] 160.9 [144.2–179.4] 183.2 [161.6–207.7]
 natural effector 22.1 [18.4–26.6] 26.6 [22.3–31.8] 21.7 [18.7–25.2] 23.8 [20.0–28.5]
 CD27− memory 15.5 [13.1–18.3] 15.3 [13.4–17.6] 14.8 [12.8–17.0] 19.2 [16.8–22.0]**
 CD27+ memory 32.8 [28.1–38.3] 36.6 [32.1–41.8] 29.0 [25.5–33.0] 36.7 [32.0–42.1]**

Geometric mean of cells/μl blood [95% CI]. CMV− and CMV+ persons were compared, as well as males and females. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Bold numbers indicate significant differences within one subset. After a multiple testing correction only values with p < 0.0014 are considered significant. Significant differences after correction for multiple testing are underlined.